Evolving vaccine discovery and development pathways for emerging pathogens.
作者信息
St John Ashley L, Ooi Eng Eong
机构信息
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Rd, Singapore, 169857, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pathology, Duke University Medical Center, Durham, NC, 27705, USA; SingHealth Duke-NUS Global Health Institute, Singapore.
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Rd, Singapore, 169857, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, 169857, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, 117549, Singapore; Department of Clinical Translational Research, Singapore General Hospital, Singapore, 169608, Singapore.
出版信息
EBioMedicine. 2024 Nov;109:105445. doi: 10.1016/j.ebiom.2024.105445. Epub 2024 Nov 6.
Abstract
摘要
相似文献
1
Evolving vaccine discovery and development pathways for emerging pathogens.针对新出现病原体的不断发展的疫苗发现与开发途径。
EBioMedicine. 2024 Nov;109:105445. doi: 10.1016/j.ebiom.2024.105445. Epub 2024 Nov 6.
2
A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.一种基于蛋白质组学的免疫信息学工具，用于加速新兴传染病背景下的 T 细胞表位发现和疫苗设计：一种面向种族的方法。
Front Immunol. 2021 Feb 26;12:598778. doi: 10.3389/fimmu.2021.598778. eCollection 2021.
3
Moving beyond Titers.超越滴度。
Vaccines (Basel). 2022 Apr 26;10(5):683. doi: 10.3390/vaccines10050683.
4
Vaccine development for bacterial pathogens: Advances, challenges and prospects.细菌病原体疫苗的研发：进展、挑战与展望。
Trop Med Int Health. 2023 Apr;28(4):275-299. doi: 10.1111/tmi.13865. Epub 2023 Mar 22.
5
Recent Development of Ruminant Vaccine Against Viral Diseases.反刍动物病毒性疾病疫苗的最新进展
Front Vet Sci. 2021 Nov 3;8:697194. doi: 10.3389/fvets.2021.697194. eCollection 2021.
6
Nanovaccines against Animal Pathogens: The Latest Findings.针对动物病原体的纳米疫苗：最新研究成果
Vaccines (Basel). 2021 Sep 4;9(9):988. doi: 10.3390/vaccines9090988.
7
Vaccinomics: a future avenue for vaccine development against emerging pathogens.疫苗组学：针对新出现病原体的疫苗开发的未来途径。
Expert Rev Vaccines. 2021 Dec;20(12):1561-1569. doi: 10.1080/14760584.2021.1987222. Epub 2021 Oct 13.
8
A guide to in silico vaccine discovery for eukaryotic pathogens.真核病原体计算疫苗发现指南。
Brief Bioinform. 2013 Nov;14(6):753-74. doi: 10.1093/bib/bbs066. Epub 2012 Oct 24.
9
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.新兴传染病疫苗：中东呼吸综合征冠状病毒和寨卡病毒带来的启示。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2918-2930. doi: 10.1080/21645515.2017.1358325. Epub 2017 Aug 28.
10
Promoting versatile vaccine development for emerging pandemics.推动针对新出现的大流行病的通用疫苗开发。
NPJ Vaccines. 2021 Feb 11;6(1):26. doi: 10.1038/s41541-021-00290-y.
本文引用的文献
1
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination.mRNA疫苗接种后，骨髓长期存在的细胞区室中不会持久建立SARS-CoV-2特异性浆细胞。
Nat Med. 2025 Jan;31(1):235-244. doi: 10.1038/s41591-024-03278-y. Epub 2024 Sep 27.
2
NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics.自然杀伤 T 细胞促进登革病毒偏向 Th1 免疫，从而控制长期保护性抗体动态。
J Clin Invest. 2024 Aug 1;134(18):e169251. doi: 10.1172/JCI169251.
3
Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children.接种疫苗儿童中对有症状 SARS-CoV-2 的保护相关因素。
Nat Med. 2024 May;30(5):1373-1383. doi: 10.1038/s41591-024-02962-3. Epub 2024 Apr 30.
4
The durability of vaccine-induced protection: an overview.疫苗诱导保护的持久性：概述。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):389-408. doi: 10.1080/14760584.2024.2331065. Epub 2024 Mar 20.
5
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.先前接种疫苗可促进记忆T细胞的早期激活，并增强SARS-CoV-2突破性感染期间的免疫反应。
Nat Immunol. 2023 Oct;24(10):1711-1724. doi: 10.1038/s41590-023-01613-y. Epub 2023 Sep 21.
6
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.用 AS03 佐剂 COVID-19 疫苗免疫恒河猴产生的针对 SARS-CoV-2 属病毒的广谱中和抗体。
Sci Transl Med. 2023 May 10;15(695):eadg7404. doi: 10.1126/scitranslmed.adg7404.
7
Promises and challenges of mucosal COVID-19 vaccines.黏膜 COVID-19 疫苗的前景与挑战。
Vaccine. 2023 Jun 19;41(27):4042-4049. doi: 10.1016/j.vaccine.2023.04.013. Epub 2023 Apr 10.
8
A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization.妊娠期产生的寨卡病毒特异性 IgM 表现出超强的中和能力。
Cell. 2022 Dec 8;185(25):4826-4840.e17. doi: 10.1016/j.cell.2022.10.023. Epub 2022 Nov 18.
9
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.诱导广泛中和抗体的 HIV-1 疫苗策略。
Nat Rev Immunol. 2023 Mar;23(3):142-158. doi: 10.1038/s41577-022-00753-w. Epub 2022 Aug 12.
10
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.预先存在的聚合酶特异性 T 细胞在 SARS-CoV-2 无血清学阴性中扩增。
Nature. 2022 Jan;601(7891):110-117. doi: 10.1038/s41586-021-04186-8. Epub 2021 Nov 10.
Zotero 插件